Online Export Import Data Search

Recent Searches: No Recent Searches
Complete Training Video : Click Here

Telangana attracts over Rs 10k cr in Life Sciences in 4 years.

Date: 13-08-2018
Subject: Telangana attracts over Rs 10k cr in Life Sciences in 4 years
Telangana, already home to pharma majors such as Aurobindo Pharma and Dr Reddy's, attracted over Rs 10,000 crore investments in the life sciences sector in the past four years, the state government said today.

This included Rs 3,000 crore in research and develoment (R&D), the government said adding its aim was to take the overall industry size to $100 billion in the future.

After the introduction of TS-iPASS (Telangana Industrial Policy) in 2015, about 700 investment proposals, including over 100 in R&D, had been approved by the state government and of this 80 percent were in the stage of project execution, an official release said.

The past four years have also seen the states life sciences sector being a magnet for investments of about Rs 10,222 crore, including Rs 3000 crore in R&D alone.

"We are happy that our policies are bearing fruit," state IT and Industries Minister K T Ramarao said. Noting that the life sciences sector added value to the lives of the people and brought laurels to the state and the country, he said the government was committed to fostering its the growth.

"We are dreaming big we want to double the size of the sector to $100 bn dollars," Telangana Minister for IT and Industries K T Rama Rao said.

The state has become home for pharma majors such as Ferring Pharma, Chemo, GSK, Syngene, Slayback Pharma, Johnson & Johnson among others.

The investments envisage about 20,000 high value R&D employments and around 50,000 manufacturing jobs in the state.

The contribution of Life Sciences sector to the overall product export value from Telangana was "a whopping" 36 percent, which has almost doubled during the last four years, the release said.

With the focus on cluster development initiatives such as Hyderabad Pharma City, Genome Valley 2.0 and the Medical Devices Park among others, the government extended "a red carpet to industry", it said.

The government had partnered with the US Pharmacopeia, an industry body that sets the standards for drugs, to set up a training institute for university graduates and pharma professionals addressing the skill gap on regulatory and data, the release added.

Source: moneycontrol.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Exim Help

What is New?

Date: 21-01-2021
Notification No.05/2021 - Customs (N.T.)
Exchange rate Notification No.05/2021-Cus (NT) dated 21.1.2021.

Date: 19-01-2021
Circular No. 1077/01/2021 - CX
Strict compliance to Limitation while filing Appeals/Petitions before Courts/ Tribunal -reg.

Date: 18-01-2021
Notification No. 8/2021-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI

Date: 18-01-2021
Notification No. 7/2021-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI

Date: 15-01-2021
Trade Notice No. 38/2020-21
Introduction of online e-PRC System for Application seeking Policy/Procedure relaxation in terms of Para 2.58 of FTP 2015-20

Date: 14-01-2021
Circular No.01/2021-Customs
Transhipment of Import & Export Cargo via Sri Lanka and Bangladesh-Waiver of bank guarantee –reg.

Date: 14-01-2021
Instruction No.01/2021-Customs
Requirement of filing of Bill of Coastal Goods (BCG) –reg.

Date: 14-01-2021
Notification No. 04/2021-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI

Date: 14-01-2021
Notification No. 05/2021-Customs (N.T./CAA/DRI)
Appointment of CAA by Pr. DGRI

Date: 12-01-2021
Notification No. 02/2021 - Central Tax
Seeks to make amendment (2021) to CGST Rules, 2017.

Exim Guru Copyright © 1999-2021 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.


C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001